Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.06 EUR
18.33 M EUR
145.56 M EUR
208.93 M
About ADVANCED MEDICAL SOLUTIONS
Sector
Industry
CEO
Andrew Christopher Meredith
Website
Headquarters
Winsford
Founded
1993
ISIN
GB0004536594
FIGI
BBG000MZL469
Advanced Medical Solutions Group Plc engages in the design, development, manufacture and distribution of wound care products, surgical dressings, medical grade materials, and medical adhesives and sutures for closing and sealing tissue. It operates through the Surgical and Woundcare segments. The Surgical segment includes the sales, marketing, research, development, and innovation of all surgical products. The Woundcare segment include all advanced woundcare sales, marketing, research, development, and innovation of all woundcare devices, regardless of whether they are sold under an AMS or a partner brand name. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ADVANCED MED.SO.GRP LS-05 stocks are traded under the ticker AQA.
We've gathered analysts' opinions on ADVANCED MED.SO.GRP LS-05 future price: according to them, AQA price has a max estimate of 3.87 EUR and a min estimate of 2.56 EUR. Watch AQA chart and read a more detailed ADVANCED MED.SO.GRP LS-05 stock forecast: see what analysts think of ADVANCED MED.SO.GRP LS-05 and suggest that you do with its stocks.
Yes, you can track ADVANCED MED.SO.GRP LS-05 financials in yearly and quarterly reports right on TradingView.
ADVANCED MED.SO.GRP LS-05 is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
AQA earnings for the last half-year are 0.06 EUR per share, whereas the estimation was 0.06 EUR, resulting in a −2.73% surprise. The estimated earnings for the next half-year are 0.08 EUR per share. See more details about ADVANCED MED.SO.GRP LS-05 earnings.
ADVANCED MED.SO.GRP LS-05 revenue for the last half-year amounts to 80.25 M EUR, despite the estimated figure of 80.26 M EUR. In the next half-year revenue is expected to reach 129.81 M EUR.
AQA net income for the last half-year is 4.93 M EUR, while the previous report showed 8.02 M EUR of net income which accounts for −38.57% change. Track more ADVANCED MED.SO.GRP LS-05 financial stats to get the full picture.
ADVANCED MED.SO.GRP LS-05 dividend yield was 1.14% in 2023, and payout ratio reached 32.24%. The year before the numbers were 0.83% and 22.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 800.00 employees. See our rating of the largest employees — is ADVANCED MED.SO.GRP LS-05 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADVANCED MED.SO.GRP LS-05 EBITDA is 35.87 M EUR, and current EBITDA margin is 24.32%. See more stats in ADVANCED MED.SO.GRP LS-05 financial statements.
Like other stocks, AQA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADVANCED MED.SO.GRP LS-05 stock right from TradingView charts — choose your broker and connect to your account.